Company Profile

Alamanda Polymers Inc
Profile last edited on: 8/7/2011      CAGE: 59AR2      UEI: JGH4FKC7GFT8

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2007
First Award
2009
Latest Award
2009
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1031 Putman Drive Suite A
Huntsville, AL 35816
   (256) 489-2529
   info@alpolymers.com
   www.alpolymers.com
Location: Single
Congr. District: 05
County: Madison

Public Profile

Alamanda Polymers deals in the production and custom synthesis of polyamino acids (PAA's) for research laboratories doing work in micro-encapsulation, gene therapy, drug delivery, cell adhesion, and surface coating. Alamanda's scientists, having more than 10 years experience in the synthesis of PAA's, have developed a polymerization process that enables complete control over the molecular weight of its polypeptides without the use of metal catalysts. Moreover, the process results in highly monodisperse products (polydispersity index: 1.01-1.2). Alamanda's process produces PAA's and PEGylated PAA's of exact chain lengths with batch-to-batch consistency. In other words, the product will contain ONLY polyamino acids of specified length, rather than a mixture. Alamanda currently offers high-purity grade or cGMP grade PAA's, batch sizes up to 5Kg, of the most commonly used homopolyamino acids. Furthermore, the catalogue contains PEGylated block co-polyamino acids that have never before been commercially available. Alamanda can also provide its expertise in PAA chemistry or custom-synthesis services for contract research. Specialties Polyamino Acids (PAA's), PEGylated PAA's, Custom Synthesis for Contract Research

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2009 1 NSF $100,000
Project Title: Well-defined PEGylated multiblock polyamino acids for protein drug delivery

Key People / Management

  Koumalen (Willy) Vayaboury -- President

  Joy Bowman -- Chief Technical Officer

  Jeffrey Schreier -- Director of Manufacturing

Company News

There are no news available.